Crossmark

Inhibition of Dipeptidylpeptidase-IV by (2S)-Cyanopyrrolidine Inhibitors of Prolyl Endopeptidase

Published Online: 2024-12-16

Published Print: 2024-12

Authors

Makarov, G. I.

Zolotov, N. N.

Pozdnev, V. F.
License Information

Text and Data Mining valid from 2024-12-01

Version of Record valid from 2024-12-01
More Information

Article History

Received: 3 February 2024

Revised: 14 February 2024

Accepted: 15 February 2024

First Online: 16 December 2024

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

: The experimental animals were kept in accordance with the sanitary and epidemiological rules SP 2.2.1.3218-14 “Sanitary and Epidemiological Requirements for the Design, Equipment and Maintenance of Experimental Biological Clinics (Vivariums).”

: All manipulations with animals were carried out in accordance with international and Russian regulatory documents: Order of the Ministry of Health of the Russian Federation no. 199n of April 1, 2016 and Directive 2010/63/EU of the European Parliament and of the Council of the European Union on the protection of animals used for scientific purposes.

: The experiments were approved by the Biomedical Ethics Committee of the Zakusov Institute of Pharmacology (protocol no. 1 of January 20, 2017). No conflicts of interest was declared by the authors.

Document is current